The answers to these and many other questions will be of great interest to PARP researchers, immunologists, and microbiologists as they are likely to uncover unique cellular processes regulated by ADP-ribosylation that could lead to the identification of novel therapeutic targets for infections or immune-mediated diseases. Here, PARP1 is linked to infection.